Statera Biopharma, Inc.
Statera Biopharma, Inc. (STAB) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · STAB · as of Jun 30, 2024
Ownership Breakdown
1
Institutional Holders
$1
Total Inst. Value
71.42M
Shares Outstanding
freeFloat 67.36%
1,000
13F Shares Held
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
STAB largest shareholders · institutional ownership
Q2 2024 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
TUCKER ASSET MANAGEMENT LLC pharmaceutical preparations | 1.0K | 0.20% | 0.20% | $1,000 | Aug 9, 2024 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2024 vs prior quarter
Q2 2024
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+0
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
STAB insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
SALUCK RANDY S. director | Sep 9, 2021 | Award | 60,000 | — | — | 60.1K | Form 4 ↗ |
Barbarick Steve K director | Sep 9, 2021 | Award | 60,000 | — | — | 60.0K | Form 4 ↗ |
Verny Lea director | Sep 9, 2021 | Award | 60,000 | — | — | 60.0K | Form 4 ↗ |
Markvicka Taunia Chief Operating Officer | Sep 28, 2021 | Award | 100,000 | — | — | 100.0K | Form 4 ↗ |
Handley Michael K President and CEO | Jul 27, 2021 | Award | 296,609 | — | — | 296.6K | Form 4 ↗ |
Buckheit Robert Chief Technology Officer | Jul 27, 2021 | Award | 24,378 | — | — | 24.4K | Form 4 ↗ |
Selsky Clifford Chief Medical Officer | Jul 27, 2021 | Award | 101,579 | — | — | 101.6K | Form 4 ↗ |
McAvoy Cozette M. Chief Legal Officer | Jul 27, 2021 | Award | 60,947 | — | — | 60.9K | Form 4 ↗ |
ARONSTAM PETER Chief Financial Officer | Jul 27, 2021 | Award | 141,370 | — | — | 141.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Statera Biopharma, Inc. (STAB) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 32.64%, while retail and public investors account for the remaining 67.36%.
The largest institutional shareholder of Statera Biopharma, Inc. is TUCKER ASSET MANAGEMENT LLC, holding approximately 1,000 shares — equal to 0.20% of outstanding shares — as of June 30, 2024.
A total of 1 institutional investors currently hold STAB stock, with a combined institutional value of approximately $1 as of the most recent 13F filing period.
Frequently asked questions
STAB ownershipStatera Biopharma, Inc. (STAB) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is TUCKER ASSET MANAGEMENT LLC with a 0.20% stake. Company insiders hold 32.64%. Data sourced from SEC Form 13F as of June 30, 2024.